Demonstration of bladder selective muscarinic receptor binding by intravesical oxybutynin to treat overactive bladder

scientific article published in November 2004

Demonstration of bladder selective muscarinic receptor binding by intravesical oxybutynin to treat overactive bladder is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/01.JU.0000138472.16876.8D
P698PubMed publication ID15540789

P2093author name stringShizuo Yamada
Ryohei Kimura
Tomomi Oki
Motoaki Saito
Ikuo Miyagawa
P433issue5 Pt 1
P407language of work or nameEnglishQ1860
P304page(s)2059-2064
P577publication date2004-11-01
P1433published inJournal of UrologyQ15709979
P1476titleDemonstration of bladder selective muscarinic receptor binding by intravesical oxybutynin to treat overactive bladder
P478volume172

Reverse relations

cites work (P2860)
Q38665319Delivery methods for drugs used in the treatment of overactive bladder
Q39516918Long-term nitric oxide deficiency causes muscarinic supersensitivity and reduces beta(3)-adrenoceptor-mediated relaxation, causing rat detrusor overactivity
Q80485600Muscarinic and alpha 1-adrenergic receptor binding characteristics of saw palmetto extract in rat lower urinary tract
Q42142992Muscarinic receptor binding, plasma concentration and inhibition of salivation after oral administration of a novel antimuscarinic agent, solifenacin succinate in mice
Q34552778Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function
Q42945632Muscarinic receptors and their mRNAs in type 2 Goto‐Kakizaki diabetic rat prostate
Q45373232The distribution of muscles fibers and their types in the female rat urethra: cytoarchitecture and three-dimensional reconstruction.
Q79190556Treatment of the overactive bladder syndrome with muscarinic receptor antagonists: a matter of metabolites?

Search more.